Search the Newsreel

Westpac Banking Corp Buys New Stake in Lumentum Holdings Inc. $LITE

Westpac Banking Corp initiated a new position in Lumentum Holdings Inc. during the first quarter, acquiring 4,685 shares valued at approximately $3.29 million. Lumentum reported strong first-quarter results with EPS of $2.37, beating estimates, and revenue growth of 90.1% year-over-year. Analyst sentiment remains largely …

Himension Capital Singapore PTE. LTD. Lowers Stock Holdings in Lumentum Holdings Inc. $LITE

Himension Capital Singapore PTE. LTD. reduced its stake in Lumentum Holdings Inc. ($LITE) by 35.3% in the first quarter, selling 10,070 shares and now owning 18,434 shares valued at $12.96 million. Despite this reduction, other institutional investors significantly increased their positions in Lumentum, with …

Telligent Fund LP Takes $1.69 Million Position in Lumentum Holdings Inc. $LITE

Telligent Fund LP has acquired a new position of 2,400 shares in Lumentum Holdings Inc. (NASDAQ:LITE), valued at approximately $1.69 million, making it their 19th largest holding. Other institutional investors like Arrowstreet Capital, Geode Capital Management, and Situational Awareness also increased their stakes in …

Mediolanum International Funds Ltd Invests $2.87 Million in Lumentum Holdings Inc. $LITE

Mediolanum International Funds Ltd has acquired a new stake in Lumentum Holdings Inc. (NASDAQ:LITE), purchasing 4,375 shares valued at approximately $2.87 million during the first quarter. This investment comes despite significant insider selling, with Lumentum insiders offloading shares worth around $38.9 million in the …

Lumentum (LITE) Stock May Be Reasonable On Cash Flow Yet Stretched On Earnings

Belite Bio, Inc (BLTE) Stock Analysis: A 37.73% Upside Potential in the Biotechnology Sector

Belite Bio, Inc (BLTE) is a clinical-stage biopharmaceutical company with a promising 37.73% upside potential, according to analyst ratings. The company is focused on developing therapies for Stargardt disease type 1 and geographic atrophy, with its lead product Tinlarebant (LBS-008) in phase 3 clinical …

EpicQuest Education Announces New AI Tutorial Platform

EpicQuest Education Group International Limited (NASDAQ: EEIQ) has announced the beta testing of its new AI tutoring platform for students at Davis University and Davis Academy, with a full launch expected in September. The platform aims to provide individualized, adaptive learning, real-time feedback, and …

Price to book forward of Amplitech Group, Inc. - Series B – NASDAQ:AMPGZ

This page provides financial information specifically on the "Price to book forward" metric for Amplitech Group, Inc. - Series B (NASDAQ: AMPGZ). It is part of TradingView's market data offerings, focusing on financials for electronic production equipment stocks. The data is made available by …

EpicQuest Education begins beta testing AI tutoring platform By Investing.com

EpicQuest Education Group International Limited (NASDAQ:EEIQ) is beta testing an AI tutoring platform for students at Davis University and Davis Academy in July, with a full launch planned for September. This platform aims to provide personalized learning support, real-time feedback, and 24/7 availability with …

EpicQuest Education Announces Beta Testing of AI Tutoring Platform for Davis University and Davis Academy Students

EpicQuest Education Group International Limited (EEIQ) has initiated beta testing for its new AI tutoring platform among students at Davis University and Davis Academy, with a full launch planned for September. This platform aims to provide personalized, adaptive learning with 24/7 availability and multilingual …

EpicQuest students will test an always-available AI tutor

EpicQuest Education (NASDAQ: EEIQ) is commencing a beta test of its new AI tutoring platform for students at Davis University and Davis Academy in July 2026. The platform aims to provide individualized, adaptive learning with 24/7 access and multilingual support, blending AI with traditional …

SEB Asset Management AB Acquires Shares of 14,288 Lumentum Holdings Inc. $LITE

SEB Asset Management AB recently acquired 14,288 shares of Lumentum Holdings Inc. worth approximately $10.0 million, marking a new position for the firm in the first quarter. Institutional ownership of Lumentum remains high at 94.05%, with several other significant institutional investments also noted. Lumentum …

Assetmark Inc. Grows Holdings in Lumentum Holdings Inc. $LITE

Assetmark Inc. significantly increased its stake in Lumentum Holdings Inc. during the first quarter of 2026, boosting its holdings by 21,974.6% to 13,907 shares, valued at approximately $9.8 million. This expansion in ownership reflects a broader trend among institutional investors, with hedge funds and …

Why Lumentum (LITE) is Poised to Beat Earnings Estimates Again

Tinlarebant retinal marker stayed stable or fell ~2%; placebo rose 20%

Belite Bio reported additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant for Stargardt disease type 1. The data, presented at ASRS 2026 Annual Meeting, showed that quantitative autofluorescence remained stable to slightly decreased in tinlarebant-treated subjects, while it increased …

LITE Stock Draws Bullish Analyst Attention Ahead Of Key Earnings

Lumentum Holdings Inc. (LITE) is attracting bullish analyst attention ahead of its fiscal Q4 and full-year 2026 earnings report, scheduled for August 11, 2026, and an upcoming Optical Communication conference. Citi has reiterated a Buy rating and placed LITE on an "upside 90-day catalyst …

Lumentum’s stock just got a lot more interesting — and Barclays has turned bullish

Barclays analyst Tom O’Malley has upgraded Lumentum Holdings (LITE) stock to overweight, citing attractive opportunities in networking following a recent selloff in optical-networking stocks. O'Malley views optical components as the most interesting subsector within the broader semiconductor universe after a period of underperformance. This …

Belite Bio completes FDA filing for tinlarebant in Stargardt disease type 1

Belite Bio has completed its New Drug Application (NDA) filing with the FDA for tinlarebant, aiming to treat Stargardt disease type 1. This news brief, generated by AI, is for informational purposes only and references original content published by Belite Bio via GlobeNewswire.

LITE Stock Jumps Over 9% As Lumentum Extends Its Stellar 2026 Run — Why Barclays Thinks There’s Still Room To Run

Lumentum's stock (LITE) surged over 9% after Barclays upgraded it to 'Overweight' with a $1,000 price target, citing a buying opportunity despite a recent pullback. Barclays believes strong underlying demand for transceivers and lasers offsets concerns about co-packaged optics adoption. Wall Street generally maintains …

Lumentum Holdings Inc Stock (LITE) Moved Up by 8.02% on Jul 20: What Signal Does It Send?

Lumentum Holdings Inc. (LITE) saw an 8.02% stock increase on July 20, driven by strong demand for high-speed optical transceivers in AI infrastructure and a recovery in the telecommunications sector. Analysts have raised price targets and earnings estimates for LITE due to improved gross …

Lumentum Holdings Jumps 9.3% Amid Sector-Wide Rally

Lumentum Holdings Inc. saw a 9.3% surge, closing at $800.61, as part of a broader rally in the communications equipment sector. This sector-wide movement, which also benefited companies like Ciena and Viavi Solutions, occurred without specific company news, suggesting investors are rotating capital into …

AmpliTech Group raises $21.9 million in rights offering

AmpliTech Group, Inc. successfully raised approximately $21.9 million through its Series A Rights Offering, which the company plans to use for general corporate purposes, including working capital, marketing, and scaling operations. This capital infusion supports AmpliTech's significant growth, with a 149% revenue surge over …

AmpliTech Receives Approximately $21.9 Million of Subscriptions in Series A Rights Offering

AmpliTech Group, Inc. announced it received approximately $21.9 million in subscriptions for its Series A Rights Offering, which closed on July 18, 2026. The company expects to issue about 4,384,163 shares of common stock and plans to use the proceeds for general corporate purposes, …

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Belite Bio announced additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant in Stargardt disease type 1 (STGD1), which demonstrated a marked divergence in quantitative autofluorescence (qAF) between treatment groups. Tinlarebant showed stable to slightly decreased qAF values, while placebo …

Barclays Upgrades Lumentum Holdings to Overweight From Equalweight, Price Target Is $1,000

Barclays has upgraded Lumentum Holdings (LITE) from Equalweight to Overweight, setting a new price target of $1,000. This upgrade indicates increased confidence from Barclays in Lumentum's future stock performance.

We Think Elite Express Holding (NASDAQ:ETS) Needs To Drive Business Growth Carefully

Elite Express Holding (NASDAQ:ETS) faces concerns due to its high cash burn rate, which increased by 1,563% in the last year, compared to a 13% growth in operating revenue. With a cash runway of only 9 months and a cash burn of US$7.0m against …

Lumentum Holdings Inc. $LITE Shares Sold by California Public Employees Retirement System

The California Public Employees Retirement System reduced its stake in Lumentum Holdings Inc. by 2.8% in the first quarter, though it still holds a significant number of shares valued at approximately $80.4 million. This trim comes amidst broader positive market sentiment for Lumentum, driven …

Price to sales forward of Amplitech Group, Inc. - Series A – BOATS:AMPGR

This article provides the "Price to sales forward" financial metric for Amplitech Group, Inc. - Series A (AMPGR) on the Blue Ocean Alternative Trade System. The content highlights a specific financial period, value, and change for this metric, indicating the company's valuation relative to …

Lumentum Stock Has Fallen 33% From Its High. Is the Optics Selloff a Gift or a Warning?

Lumentum Holdings (LITE) stock experienced a significant 33% drawdown from its 52-week high, despite no fundamental business deterioration. This selloff has led to a divided Wall Street, with some analysts maintaining Hold ratings due to high valuation multiples, while others reaffirm Buy ratings, anticipating …

World Equity Group Inc. Takes Position in Lumentum Holdings Inc. $LITE

World Equity Group Inc. recently initiated a new position in Lumentum Holdings Inc. by purchasing 1,421 shares valued at approximately $999,000 during the first quarter. Lumentum reported strong first-quarter financial results, with EPS of $2.37 beating expectations and revenue up 90.1% year over year …

Independent Financial Group LLC Purchases New Position in Lumentum Holdings Inc. $LITE

Independent Financial Group LLC has acquired a new position in Lumentum Holdings Inc. ($LITE), purchasing 3,965 shares valued at approximately $2.79 million in the first quarter. This aligns with strong institutional ownership, where 94.05% of Lumentum shares are held by hedge funds and institutional …

Wealthfront Advisers LLC Buys 8,635 Shares of Lumentum Holdings Inc. $LITE

Wealthfront Advisers LLC significantly increased its stake in Lumentum Holdings Inc. (NASDAQ:LITE) by 1,196% in the first quarter, purchasing 8,635 shares and bringing their total holding to 9,357 shares valued at $6.6 million. This increased institutional interest follows Lumentum's better-than-expected quarterly earnings and strong …

Hanseatic Management Services Inc. Acquires New Holdings in Lumentum Holdings Inc. $LITE

Hanseatic Management Services Inc. has acquired a new position in Lumentum Holdings Inc. (NASDAQ:LITE), purchasing 3,806 shares valued at approximately $2,675,000. This investment makes Lumentum the firm's third-largest holding, representing 2.6% of its portfolio. The article also details other institutional investor activities, recent analyst …

11,800 Shares in Lumentum Holdings Inc. $LITE Acquired by Freemont Management S.A.

Freemont Management S.A. has acquired a new stake of 11,800 shares in Lumentum Holdings Inc. (NASDAQ:LITE), valued at approximately $8.29 million, making it their 26th largest holding. Several other institutional investors also increased their positions in Lumentum, highlighting growing investor interest. The company has …

Pidilite Industries Limited (NSE:PIDILITIND) Passed Our Checks, And It's About To Pay A ₹11.50 Dividend

Lumentum Holdings Inc (LU2) Q1 2026 Earnings Report - Results, Call & Slides

Lumentum Holdings Inc. (LU2) reported its Q1 2026 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of €0.96 against a consensus of €0.90, and actual revenue of €466.60M, surpassing the expected €460.19M. Year-over-year revenue growth stood at an impressive …